The shares are listed on the Nasdaq Global Market

Davis Polk advised the sales agent in connection with the SEC-registered at-the-market offering by Ardelyx, Inc. of its common stock for up to an aggregate amount of $150 million. The common stock is listed on the Nasdaq Global Market under the symbol “ARDX.”

Based in Fremont, California, Ardelyx, Inc. is a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs.

The Davis Polk corporate team included partner Stephen Salmon and associates Paula Gergen and Sunny Xu. Associate Alison T. Chin provided intellectual property advice. Members of the Davis Polk team are based in the Northern California and New York offices.

Copy link to share post